Quick Answer
Cannabis Bioscience International Holdings, Inc. reported Total Revenue of $303.0 thousand for fiscal year 2025.
Cannabis Bioscience International Holdings, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | $303.0K +21.8% |
$248.8K -21.5% |
$316.8K | — |
| Net Income | -$548.8K +15.7% |
-$651.3K +36.9% |
-$1.03M | — |
| Diluted EPS | -$0.00 +0.0% |
-$0.00 +0.0% |
-$0.00 | — |
| Total Assets | $31.9K -44.2% |
$57.2K +31.8% |
$43.4K | — |
| Stockholders Equity | -$1.16M -7.8% |
-$1.08M -82.4% |
-$591.7K -63.9% |
-$361.1K |
| Operating Income | -$421.4K +13.3% |
-$486.1K +50.6% |
-$983.4K | — |
| Gross Profit | $262.9K +29.4% |
$203.2K -9.0% |
$223.4K | — |
| Shares Outstanding | 11.63B +11.5% |
10.43B +3.7% |
10.06B | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | November 30, 2025 | $53.3K | -28.3% | +120.1% |
| Net Income | November 30, 2025 | -$117.0K | -47.1% | -41.5% |
| Diluted EPS | November 30, 2025 | $0.00 | — | — |
| Total Assets | November 30, 2025 | $22.1K | — | +16.8% |
| Cash and Equivalents | February 29, 2012 | $73.5K | -79.1% | -74.6% |
| Stockholders Equity | November 30, 2025 | -$1.36M | -20.1% | -9.4% |
| Operating Income | November 30, 2025 | -$95.9K | -60.8% | -28.2% |
| Gross Profit | November 30, 2025 | $42.8K | -35.6% | +166.3% |
| Shares Outstanding | November 30, 2025 | 11.63B | — | +0.0% |
- Cannabis Bioscience International Holdings, Inc. reported Total Revenue of $303.0 thousand for fiscal year 2025.
- Cannabis Bioscience International Holdings, Inc. showed an increase of +21.8% in Total Revenue compared to the prior fiscal year.
- Cannabis Bioscience International Holdings, Inc. reported Net Income of -$548.8 thousand for fiscal year 2025.
- Cannabis Bioscience International Holdings, Inc. showed an increase of +15.7% in Net Income compared to the prior fiscal year.
- Cannabis Bioscience International Holdings, Inc. reported Diluted EPS of $0.00 per share (loss) for fiscal year 2025.
- Cannabis Bioscience International Holdings, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Cannabis Bioscience International Holdings, Inc. reported Total Assets of $31.9 thousand for fiscal year 2025.
- Cannabis Bioscience International Holdings, Inc. showed a decrease of -44.2% in Total Assets compared to the prior fiscal year.
- Cannabis Bioscience International Holdings, Inc. reported Stockholders Equity of -$1.16 million for fiscal year 2025.
- Cannabis Bioscience International Holdings, Inc. showed a decrease of -7.8% in Stockholders Equity compared to the prior fiscal year.
- Cannabis Bioscience International Holdings, Inc. reported Operating Income of -$421.4 thousand for fiscal year 2025.
- Cannabis Bioscience International Holdings, Inc. showed an increase of +13.3% in Operating Income compared to the prior fiscal year.
- Cannabis Bioscience International Holdings, Inc. reported Gross Profit of $262.9 thousand for fiscal year 2025.
- Cannabis Bioscience International Holdings, Inc. showed an increase of +29.4% in Gross Profit compared to the prior fiscal year.
- Cannabis Bioscience International Holdings, Inc. reported Shares Outstanding of 11.63 billion shares for fiscal year 2025.
- Cannabis Bioscience International Holdings, Inc. showed an increase of +11.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: